Cargando…
Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada
From the Southwestern Ontario database, one of the largest primary-care datasets in Canada, 1,263 patients with osteoarthritis (OA) of one or both knees were identified who received two consecutive series of intra-articular (IA) injections of hylan G-F 20 preparation and no other prescribed OA medic...
Autores principales: | Petrella, Robert J, Wakeford, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610793/ https://www.ncbi.nlm.nih.gov/pubmed/26508838 http://dx.doi.org/10.2147/DDDT.S88473 |
Ejemplares similares
-
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
por: Webb, David, et al.
Publicado: (2018) -
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action
por: Moreland, Larry W
Publicado: (2003) -
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2019) -
Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017) -
Total Knee Replacement Delayed With Hylan G-F 20 Use in Patients With Grade IV Osteoarthritis
por: Waddell, David D., et al.
Publicado: (2007)